主题：【原创】方舟子，还有司马南 -- 淡山客

SCLC cell culture

NCI-H82 cell line was derived by Gazdar in 1978 from the pleural fluid of a 40-year-old patient with SCLC. This cell line has been well characterized and used as an in vitro model for studying lung cancer [15, 16]. Cells were cultured in 24-well plates with Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal calf serum and 1% Pen/Strep in a 37°C incubator with 5% CO2.

YXQ-EQ treatment

NCI-H82 cells were treated with YXQ-EQ as described previously [13].